CARMINE J DEFUSCO

Allopathic & Osteopathic Physicians|Allergy & Immunology MANALAPAN, NJ NPI 1942270616

General Payments — all program years on this page

$3,269.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 176
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $244.47 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $244.4715

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $45.393
Amgen Inc. $42.983
PFIZER INC. $35.952
GENZYME CORPORATION $34.432
Genentech USA, Inc. $34.392
Kaleo, Inc. $21.641
GlaxoSmithKline, LLC. $14.881
Relypsa, Inc. $14.811

By program year

Program yearAmountRecords
2018 $282.8620
2019 $381.8821
2020 $260.8115
2021 $452.0133
2022 $718.6737
2023 $928.3835
2024 $244.4715

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104249041 AstraZeneca Pharmaceuticals LP $16.58 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104432145 AstraZeneca Pharmaceuticals LP $13.71 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105650980 AstraZeneca Pharmaceuticals LP $15.10 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111560739 Amgen Inc. $13.80 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111560741 Amgen Inc. $14.32 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111560743 Amgen Inc. $14.86 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116306707 GlaxoSmithKline, LLC. $14.88 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124052580 Vifor Pharma, Inc. $14.81 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126623374 kaleo, Inc. $21.64 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131508196 PFIZER INC. $18.96 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131744000 PFIZER INC. $16.99 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132984527 Genentech USA, Inc. $15.84 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132984531 Genentech USA, Inc. $18.55 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139577310 GENZYME CORPORATION $18.24 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139577374 GENZYME CORPORATION $16.19 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.